Kiem Vu, Ph.D. - Publications

2012 Pharmacology and Toxicology University of California, Davis, Davis, CA 
Cell Biology, Pharmacy, Biochemistry

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Vu K, Blumwald E, Gelli A. The Antifungal Activity of HMA, an Amiloride Analog and Inhibitor of Na/H Exchangers. Frontiers in Microbiology. 12: 673035. PMID 34025629 DOI: 10.3389/fmicb.2021.673035  1
2020 Aaron PA, Vu K, Gelli A. An Antivirulence Approach for Preventing Cryptococcus neoformans from Crossing the Blood-Brain Barrier via Novel Natural Product Inhibitors of a Fungal Metalloprotease. Mbio. 11. PMID 32694141 DOI: 10.1128/Mbio.01249-20  1
2019 Vu K, Garcia JA, Gelli A. Cryptococcal Meningitis and Anti-virulence Therapeutic Strategies. Frontiers in Microbiology. 10: 353. PMID 30863389 DOI: 10.3389/Fmicb.2019.00353  1
2018 Na Pombejra S, Jamklang M, Uhrig JP, Vu K, Gelli A. The structure-function analysis of the Mpr1 metalloprotease determinants of activity during migration of fungal cells across the blood-brain barrier. Plos One. 13: e0203020. PMID 30161190 DOI: 10.1371/Journal.Pone.0203020  1
2018 Vu K, Thompson GR, Roe CC, Sykes JE, Dreibe EM, Lockhart SR, Meyer W, Engelthaler DM, Gelli A. Flucytosine resistance in Cryptococcus gattii is indirectly mediated by the FCY2-FCY1-FUR1 pathway. Medical Mycology. PMID 29554336 DOI: 10.1093/Mmy/Myx135  1
2015 Yang ML, Uhrig J, Vu K, Singapuri A, Dennis M, Gelli A, Thompson GR. Fluconazole Susceptibility in Cryptococcus gattii is dependent on the ATP binding cassette (ABC) Transporter PDR11. Antimicrobial Agents and Chemotherapy. PMID 26643330 DOI: 10.1128/Aac.01777-15  1
2015 Vu K, Bautos JM, Gelli A. The Cch1-Mid1 High-Affinity Calcium Channel Contributes to the Virulence of Cryptococcus neoformans by Mitigating Oxidative Stress. Eukaryotic Cell. 14: 1135-43. PMID 26385891 DOI: 10.1128/Ec.00100-15  1
2014 Vu K, Tham R, Uhrig JP, Thompson GR, Na Pombejra S, Jamklang M, Bautos JM, Gelli A. Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. Mbio. 5: e01101-14. PMID 24895304 DOI: 10.1128/Mbio.01101-14  1
2013 Vu K, Eigenheer RA, Phinney BS, Gelli A. Cryptococcus neoformans promotes its transmigration into the central nervous system by inducing molecular and cellular changes in brain endothelial cells. Infection and Immunity. 81: 3139-47. PMID 23774597 DOI: 10.1128/Iai.00554-13  1
2013 Hong MP, Vu K, Bautos JM, Tham R, Jamklang M, Uhrig JP, Gelli A. Activity of the calcium channel pore Cch1 is dependent on a modulatory region of the subunit Mid1 in Cryptococcus neoformans. Eukaryotic Cell. 12: 142-50. PMID 23175710 DOI: 10.1128/Ec.00130-12  1
2010 Hong MP, Vu K, Bautos J, Gelli A. Cch1 restores intracellular Ca2+ in fungal cells during endoplasmic reticulum stress. The Journal of Biological Chemistry. 285: 10951-8. PMID 20123986 DOI: 10.1074/Jbc.M109.056218  1
2010 Vu K, Gelli A. Astemizole and an analogue promote fungicidal activity of fluconazole against Cryptococcus neoformans var. grubii and Cryptococcus gattii. Medical Mycology. 48: 255-62. PMID 19572230 DOI: 10.3109/13693780903081968  1
2009 Vu K, Weksler B, Romero I, Couraud PO, Gelli A. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryotic Cell. 8: 1803-7. PMID 19767445 DOI: 10.1128/Ec.00240-09  1
2009 Vu K, Bautos J, Hong MP, Gelli A. The functional expression of toxic genes: lessons learned from molecular cloning of CCH1, a high-affinity Ca2+ channel. Analytical Biochemistry. 393: 234-41. PMID 19580778 DOI: 10.1016/J.Ab.2009.06.039  1
Show low-probability matches.